EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo

Hannah L H Green, Hashum Sum, Palak Sinha, Asjad Visnagri, Sang-Hyuck Lee, Anastasia Baffour-Kyei, Hyunah Lee, Francisco Santos, Konstantinos Theofilatos, Alison C Brewer

Journal of Biological Chemistry · 2025-09 · 301 (9) · 110520

DOI: 10.1016/j.jbc.2025.110520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-09. Verfasst von Hannah L H Green und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London, UK. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Hyperglycemia, Proto-Oncogene Proteins, Endothelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated DNA methylation in the endothelium is associated with the development of cardiovascular disease. Ten-eleven translocation 2 (TET2), a DNA demethylase, plays a regulatory role in endothelial function. Loss of endothelial-expressed TET2 correlates with atherosclerosis progression in vivo and alters vasoactive signaling in vitro. Hyperglycemia acts to downregulate TET2 stability and activity in endothelial cells, but the relevance of this to endothelial dysfunction in diabetes remains unclear. Here, we explore the transcriptional and functional consequences of endothelial-specific TET2 loss in vivo and assess the role of DNA methylation in TET2-dependent transcriptional regulation. Ex vivo aortic responses to acetylcholine and phenylephrine were equivalent between wild-type and endothelial-specific TET2 knockout (TET2KO) mice. RNA sequencing of endothelial-enriched lung cells from TET2KO mice revealed significant dysregulation of interferon signaling. In cultured endothelial cells, qPCR, hydroxymethylated-DNA immunoprecipitation sequencing, and nanopore sequencing showed that IFITM1 and ISG15-classical interferon-responsive genes-were negatively regulated by TET2 independent of DNA demethylation. Conversely, the IFNγ-inducible chemokines CXCL9 and CXCL10 were positively regulated by TET2 in a mechanism involving catalytic demethylation, as evidenced by increased 5hmC and decreased 5 mC at an enhancer region. Strikingly, approximately 70% of transcriptional changes observed in TET2KO endothelium were mirrored in diabetic mouse endothelium. Pathway analysis highlighted dysregulation of interferon signaling and altered glycosaminoglycan metabolism as the most significant biological consequences. In summary, endothelial TET2 loss leads to transcriptional dysregulation of interferon-regulated genes, partly through altered DNA methylation. This may have relevance to the susceptibility of diabetics to recurrent viral infections and endothelial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsHyperglycemiaProto-Oncogene ProteinsEndothelial CellsAnimalsDioxygenasesMiceMice, KnockoutDNA MethylationHumansSignal TransductionMice, Inbred C57BLMale

Stichwörter der Autor:innen

DNA methylationTET2diabetesendothelial cellendothelial dysfunctionepigeneticsinterferonnanopore sequencing

Substanzen

DioxygenasesTet2 protein, mouseDNA-Binding ProteinsProto-Oncogene Proteins

Autor:innen und Institutionen

  • School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London, UK.
  • Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London, UK. Electronic address: alison.brewer@kcl.ac.uk.

Förderung

  • British Heart Foundation

Zitieren

APA

Green, H. L. H., Sum, H., Sinha, P., Visnagri, A., Lee, S. H., Baffour-Kyei, A., Lee, H., Santos, F., Theofilatos, K., & Brewer, A. C. (2025). TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo. Journal of Biological Chemistry, 301(9), 110520. https://doi.org/10.1016/j.jbc.2025.110520

Vancouver

Green HLH, Sum H, Sinha P, Visnagri A, Lee SH, Baffour-Kyei A, et al. TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo. Journal of Biological Chemistry. 2025;301(9):110520. doi:10.1016/j.jbc.2025.110520

BibTeX
@article{Green2025,
  author = {Green, Hannah L H and Sum, Hashum and Sinha, Palak and Visnagri, Asjad and Lee, Sang-Hyuck and Baffour-Kyei, Anastasia and Lee, Hyunah and Santos, Francisco and Theofilatos, Konstantinos and Brewer, Alison C},
  title = {TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivo},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {9},
  pages = {110520},
  doi = {10.1016/j.jbc.2025.110520}
}
Kostenlos starten →